{"id":"https://openalex.org/W2484614442","doi":"https://doi.org/10.1158/1538-7445.am2016-2989","title":"Abstract 2989: An Intact G1/S checkpoint determines response to CDK4/6 inhibitor in breast cancer","display_name":"Abstract 2989: An Intact G1/S checkpoint determines response to CDK4/6 inhibitor in breast cancer","publication_year":2016,"publication_date":"2016-07-15","ids":{"openalex":"https://openalex.org/W2484614442","doi":"https://doi.org/10.1158/1538-7445.am2016-2989","mag":"2484614442"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2016-2989","doi":"https://doi.org/10.1158/1538-7445.am2016-2989","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2016-2989","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5006097717","display_name":"Smruthi Vijayaraghavan","orcid":"https://orcid.org/0000-0002-8131-0988","observed_orcids":["https://orcid.org/0000-0002-8131-0988"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Smruthi Vijayaraghavan","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5042960706","display_name":"Khandan Keyomarsi","orcid":"https://orcid.org/0000-0002-5440-0849","observed_orcids":["https://orcid.org/0000-0002-5440-0849"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Khandan Keyomarsi","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1343551460"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"76","issue":"14_Supplement","first_page":"2989","last_page":"2989"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/palbociclib","display_name":"palbociclib","score":0.8339999914169312},{"id":"https://openalex.org/keywords/cdk4-6-inhibitors","display_name":"CDK4/6 inhibitors","score":0.9309999942779541},{"id":"https://openalex.org/keywords/g1-s-checkpoint","display_name":"G1/S checkpoint","score":0.859000027179718},{"id":"https://openalex.org/keywords/estrogen-receptor-positive-breast-cancer","display_name":"estrogen receptor-positive breast cancer","score":0.8169999718666077},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.6389999985694885},{"id":"https://openalex.org/keywords/senescence","display_name":"senescence","score":0.796999990940094},{"id":"https://openalex.org/keywords/rb-phosphorylation","display_name":"retinoblastoma protein phosphorylation","score":0.7379999756813049},{"id":"https://openalex.org/keywords/cell-cycle-dysregulation","display_name":"cell cycle dysregulation","score":0.6940000057220459},{"id":"https://openalex.org/keywords/mcf-7-cells","display_name":"MCF-7 cells","score":0.6190000176429749},{"id":"https://openalex.org/keywords/t47d-cells","display_name":"T47D cells","score":0.9900000095367432},{"id":"https://openalex.org/keywords/mcf10a","display_name":"MCF10A","score":0.9449999928474426},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.6129999756813049},{"id":"https://openalex.org/keywords/mechanism-of-action","display_name":"mechanism of action","score":0.5189999938011169}],"concepts":[{"id":"https://openalex.org/C2779744173","wikidata":"https://www.wikidata.org/wiki/Q15269707","display_name":"Palbociclib","level":5,"score":0.9730559587478638},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6115437150001526},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5620467066764832},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5587171316146851},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5577060580253601},{"id":"https://openalex.org/C105696609","wikidata":"https://www.wikidata.org/wiki/Q1068809","display_name":"Cell cycle checkpoint","level":4,"score":0.5083979964256287},{"id":"https://openalex.org/C124320809","wikidata":"https://www.wikidata.org/wiki/Q46292","display_name":"Cyclin-dependent kinase","level":4,"score":0.4985775947570801},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.4594140946865082},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.43701642751693726},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.4107666611671448},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4084528088569641},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.35629090666770935},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3093058168888092},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2609548270702362},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.10823780298233032}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2016-2989","doi":"https://doi.org/10.1158/1538-7445.am2016-2989","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2016-2989","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2508981226","https://openalex.org/W381087551","https://openalex.org/W2740995472","https://openalex.org/W2398150337","https://openalex.org/W2549197577","https://openalex.org/W2487412721","https://openalex.org/W2555512044","https://openalex.org/W3178621611","https://openalex.org/W3115380242","https://openalex.org/W2407580832"],"abstract_inverted_index":{"Abstract":[0],"Deregulation":[1],"of":[2,10,17,73,80,84,92,115,119,128,140,165,170,179,248,262,274,284,302,306,313,346,380,413,432,436,467,472],"the":[3,14,56,71,81,88,138,163,222,235,249,260,268,311,357,378,389,411,439,468,473],"cell":[4,18,184,192,200,224,292],"cycle":[5,19,201,293],"machinery":[6],"is":[7,38,87,110,131,151,332,418],"a":[8,34,176,189,212,231,336,371,395],"hallmark":[9],"most":[11],"cancers,":[12],"making":[13],"positive":[15],"regulators":[16],"such":[20],"as":[21,26,434],"Cyclin":[22],"dependent":[23],"kinases":[24],"(CDKs)":[25],"attractive":[27],"and":[28,47,97,117,136,145,148,167,188,203,217,239,266,295,304,323,374,430],"druggable":[29],"targets.":[30],"Palbociclib":[31,64,331,364],"or":[32],"PD-0332991,":[33],"potent":[35],"CDK4/6":[36,338,390,459],"inhibitor":[37,460],"an":[39,414],"anti-proliferative":[40],"agent":[41],"that":[42,207,299,344,363,388,410],"induces":[43,211],"G1":[44,218],"arrest,":[45],"senescence":[46,204,229,296],"inhibits":[48],"tumor":[49],"growth":[50,215],"in":[51,59,106,121,157,221,230,234,241,286,349,394,402,441,461],"breast":[52,76,123,182,314,403,443,462],"cancer.":[53,77,124,463],"Based":[54],"on":[55],"drug's":[57,358],"success":[58],"phase":[60],"II":[61],"clinical":[62,107],"trials,":[63,108],"was":[65],"recently":[66],"awarded":[67],"FDA":[68],"approval":[69],"for":[70,420,476],"treatment":[72,86,141,208],"metastatic":[74],"ER+":[75,122,181,223,236,442],"However,":[78],"one":[79],"main":[82],"limitations":[83],"this":[85,149,375],"associated":[89],"adverse":[90],"events":[91],"grade":[93,98],"3&4":[94,99],"neutropenia":[95],"(62%)":[96],"leukopenia":[100],"(25.2%).":[101],"Moreover,":[102,329],"despite":[103],"promising":[104],"results":[105,408],"little":[109],"known":[111,279,333],"about":[112],"palbociclib's":[113],"mechanism":[114,164],"action":[116,166],"mode(s)":[118],"resistance":[120,144],"A":[125],"clear":[126],"understanding":[127],"these":[129,155],"mechanisms":[130],"critical":[132],"to":[133,161,172,244,256,280,317,320,326,334,398,422,426,438,458],"identify":[134,168],"biomarkers":[135,435],"understand":[137],"biology":[139],"response,":[142,291],"drug":[143,197,340,440],"combination":[146],"strategies,":[147],"study":[150,386],"aimed":[152],"at":[153,370],"addressing":[154],"gaps":[156],"knowledge.":[158],"In":[159],"order":[160],"examine":[162],"nodes":[169],"sensitivity":[171,312],"Palbociclib,":[173,392],"we":[174,258],"used":[175],"model":[177,288,351],"system":[178,352],"two":[180],"cancer":[183,237,315,404,444],"lines":[185],"(MCF7,":[186],"T47D)":[187],"mammary":[190],"epithelial":[191],"line":[193],"(MCF10A).":[194],"Results":[195],"from":[196],"response":[198,341,421,437,457],"studies,":[199],"analysis":[202,294],"assay":[205,297],"revealed":[206,298],"with":[209],"palbociclib":[210,227,318],"dose-dependent":[213,232,396],"sustained":[214],"inhibition":[216],"arrest":[219],"specifically":[220,401],"lines.":[225],"Additionally,":[226],"induced":[228],"manner":[233,397],"cells":[238,254,316],"not":[240,354],"MCF10A.":[242],"Further,":[243,406],"interrogate":[245],"if":[246],"deregulation":[247],"G1/S":[250,416,454],"checkpoint":[251,417,455],"can":[252],"render":[253],"resistant":[255],"palbociclib,":[257,423],"examined":[259],"effect":[261],"knocking":[263],"down":[264],"Rb":[265,303,428],"overexpressing":[267],"oncogenic":[269],"low":[270],"molecular":[271],"weight":[272],"isoforms":[273],"cyclin-E":[275],"(LMW-E),":[276],"which":[277],"are":[278],"induce":[281,327,399],"constitutive":[282],"phosphorylation":[283],"Rb,":[285],"our":[287,350,381,385,407],"system.":[289],"Drug":[290],"both":[300],"downregulation":[301,345],"overexpression":[305],"LMW-E":[307,433],"expression":[308],"significantly":[309],"diminished":[310],"(\u223c6":[319],"7":[321],"fold)":[322],"its":[324],"ability":[325],"senescence.":[328],"while":[330],"be":[335,377],"specific":[337],"inhibitor,":[339,391],"studies":[342],"showed":[343],"either":[347],"kinase":[348],"did":[353],"completely":[355],"recapitulate":[356],"anti-tumor":[359],"effects.":[360],"This":[361],"suggests":[362],"could":[365],"inhibit":[366],"another":[367],"target,":[368],"albeit,":[369],"higher":[372],"concentration,":[373],"would":[376],"subject":[379],"future":[382],"studies.":[383],"Collectively,":[384],"indicates":[387],"acts":[393],"senescence,":[400],"cells.":[405],"suggest":[409],"presence":[412],"intact":[415],"necessary":[419],"providing":[424],"rationale":[425],"utilize":[427],"positivity":[429],"absence":[431],"patients.":[445],"Citation":[446],"Format:":[447],"Smruthi":[448],"Vijayaraghavan,":[449],"Khandan":[450],"Keyomarsi.":[451],"An":[452],"Intact":[453],"determines":[456],"[abstract].":[464],"In:":[465],"Proceedings":[466],"107th":[469],"Annual":[470],"Meeting":[471],"American":[474],"Association":[475],"Cancer":[477,488],"Research;":[478],"2016":[479],"Apr":[480],"16-20;":[481],"New":[482],"Orleans,":[483],"LA.":[484],"Philadelphia":[485],"(PA):":[486],"AACR;":[487],"Res":[489],"2016;76(14":[490],"Suppl):Abstract":[491],"nr":[492],"2989.":[493]},"counts_by_year":[],"updated_date":"2026-08-21T09:56:20.448147","created_date":"2016-08-23T00:00:00"}